Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

Factors Affecting Drug Distribution: Physiological Barriers

Factors Affecting Drug Distribution: Physiological Barriers

Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Drug Delivery: Miscellaneous Routes

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Physiological Barriers

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Novel Technique for Intracameral Pressure Measurement in Clinical Practice.

Ophthalmology. Glaucoma·2026

Same author

The Emory Optic Nerve Head Atlas - Using 3D Anatomical Mapping to Study Optic Neuropathies with an Initial Focus on Glaucoma.

ArXiv·2025

Same author

Impact of social determinants of health and medication burden on quality of life and disease severity in glaucoma.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2025

Same author

Peripheral visual field loss and activities of daily living.

Current opinion in neurology·2022

Same author

Pragmatic adjunctive usage of netarsudil: A retrospective chart review from a tertiary care center.

Indian journal of ophthalmology·2022

Same author

Effects of Acute Intracranial Pressure Changes on Optic Nerve Head Morphology in Humans and Pig Model.

Current eye research·2021

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

Barriers to glaucoma drug delivery.

Deepta Ghate¹, Henry F Edelhauser

¹Emory University Eye Center, Atlanta, GA 30322, USA.

Journal of Glaucoma

|March 18, 2008

Summary

This review explores topical glaucoma treatments, focusing on drug delivery, ocular barriers, and formulation advancements. New therapies and delivery routes aim to improve efficacy and patient compliance.

Area of Science:

Ophthalmology
Pharmacology
Biomaterials Science

Background:

Topical medications are the primary treatment for glaucoma.
Effective ocular drug delivery faces challenges from anatomical and physiological barriers.
Improving patient compliance is crucial for managing chronic ocular conditions like glaucoma.

Purpose of the Study:

To review the pharmacokinetics of topical ophthalmic medications.
To discuss ocular barriers affecting drug penetration.
To explore advancements in ophthalmic drug formulation and delivery systems for enhanced efficacy and compliance.

Main Methods:

Literature review of pharmacokinetic studies.
Analysis of ocular barriers to topical drug delivery.

More Related Videos

Intracameral Injection in Rats with Low Risk of Adverse Effects

Intracameral Injection in Rats with Low Risk of Adverse Effects

Published on: May 31, 2024

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

Related Experiment Videos

Last Updated: Jul 6, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

Intracameral Injection in Rats with Low Risk of Adverse Effects

Intracameral Injection in Rats with Low Risk of Adverse Effects

Published on: May 31, 2024

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

Examination of novel ophthalmic drug formulations and delivery vehicles.

Discussion of emerging surgical and therapeutic approaches.

Main Results:

Ophthalmic drug formulation significantly impacts drug delivery efficiency and side effect profiles.
New vehicles and formulations show potential for reduced dosing frequency and improved patient adherence.
Advances in material science are enabling innovative drug delivery systems for ocular diseases.

Conclusions:

Optimizing ophthalmic drug formulation is key to overcoming ocular barriers and enhancing therapeutic outcomes in glaucoma.
Future directions include developing advanced drug delivery systems and exploring novel routes for ocular drug administration, including neuroprotection.
Innovations in drug delivery aim to improve treatment efficacy, minimize side effects, and increase patient compliance for better glaucoma management.